ad image

Clinical Development

1 / 1
EQT
Financing

EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics

EQT

PR-11-24-NI-116Nov 20, 2024
Neurocrine Biosciences
Bioscience

Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules

Neurocrine Biosciences

PR-10-24-NI-71Nov 04, 2024
AbbVie
Financing

AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline

AbbVie

PR-10-24-NI-65Oct 29, 2024
Abbott
Clinical Trial

Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure

Abbott

PR-10-24-NI-61Oct 25, 2024
Children's Hospital of Philadelphia
Clinical Development

Children's Hospital of Philadelphia Researchers Find Promising New Immunotherapy Target in Neuroblastoma and Other Cancers

Children's Hospital of Philadelphia

PR-10-24-NI-60Oct 25, 2024
Dotmatics
Clinical Development

Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery

Dotmatics

PR-10-24-NI-57Oct 22, 2024
Inovio Pharmaceuticals, Inc.
Clinical Trials

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP

Inovio Pharmaceuticals, Inc.

PR-10-24-NI-53Oct 21, 2024
MOBILion Systems, Inc.
Clinical Development

MOBILion Systems Unveils Novel High Resolution Mass Spectrometry Functionality for Proteomics Workflows

MOBILion Systems, Inc.

PR-10-24-NI-51Oct 21, 2024
Triumvira Immunologics Inc.
Clinical Trials

Triumvira Immunologics Announces Publication Demonstrating the Safety and Efficacy of TAC T Cells Targeting Claudin 18.2

Triumvira Immunologics Inc.

PR-10-24-NI-47Oct 16, 2024
Anixa Biosciences
Clinical Development

Anixa Biosciences appoints Suyasha Gupta as Senior Director of Clinical Development

Anixa Biosciences

PR-10-24-NI-34Oct 07, 2024
1 / 1